Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 931Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 13JANSSEN PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BIO CEO & Investor
Not Confirmed
arrow
BIO CEO & Investor
Not Confirmed

RIVAROXABAN

US Patent Number : 9539218

Drug Substance Claim :

Drug Product Claim :

Application Number : 22406

Patent Use Code : U-1955

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-17

blank

02

arrow
BIO CEO & Investor
Not Confirmed
arrow
BIO CEO & Investor
Not Confirmed

RIVAROXABAN

US Patent Number : 9539218

Drug Substance Claim :

Drug Product Claim :

Application Number : 22406

Patent Use Code : U-1954

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-17

blank

03

arrow
BIO CEO & Investor
Not Confirmed
arrow
BIO CEO & Investor
Not Confirmed

RIVAROXABAN

US Patent Number : 9539218

Drug Substance Claim :

Drug Product Claim :

Application Number : 22406

Patent Use Code : U-1957

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-17

blank

04

arrow
BIO CEO & Investor
Not Confirmed
arrow
BIO CEO & Investor
Not Confirmed

RIVAROXABAN

US Patent Number : 9539218

Drug Substance Claim :

Drug Product Claim :

Application Number : 22406

Patent Use Code : U-1953

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-17

blank

05

arrow
BIO CEO & Investor
Not Confirmed
arrow
BIO CEO & Investor
Not Confirmed

RIVAROXABAN

US Patent Number : 9539218

Drug Substance Claim :

Drug Product Claim :

Application Number : 22406

Patent Use Code : U-1953

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-17

blank

06

arrow
BIO CEO & Investor
Not Confirmed
arrow
BIO CEO & Investor
Not Confirmed

RIVAROXABAN

US Patent Number : 9539218

Drug Substance Claim :

Drug Product Claim :

Application Number : 22406

Patent Use Code : U-2641

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-17

blank

07

arrow
BIO CEO & Investor
Not Confirmed
arrow
BIO CEO & Investor
Not Confirmed

RIVAROXABAN

US Patent Number : 9539218

Drug Substance Claim :

Drug Product Claim :

Application Number : 22406

Patent Use Code : U-3285

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-17

blank

08

arrow
BIO CEO & Investor
Not Confirmed
arrow
BIO CEO & Investor
Not Confirmed

RIVAROXABAN

US Patent Number : 9539218

Drug Substance Claim :

Drug Product Claim :

Application Number : 22406

Patent Use Code : U-2143

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-17

blank

09

arrow
BIO CEO & Investor
Not Confirmed
arrow
BIO CEO & Investor
Not Confirmed

RIVAROXABAN

US Patent Number : 9539218

Drug Substance Claim :

Drug Product Claim :

Application Number : 22406

Patent Use Code : U-3288

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-17

blank

10

arrow
BIO CEO & Investor
Not Confirmed
arrow
BIO CEO & Investor
Not Confirmed

RIVAROXABAN

US Patent Number : 9539218

Drug Substance Claim :

Drug Product Claim :

Application Number : 22406

Patent Use Code : U-3289

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-17

blank